We have shown that CD8+CD28− Tregs are significantly increased numerically in the peripheral blood (PB) of RA patients treated with methotrexate (RA(MTX)) but exert reduced suppressor function compared to healthy individuals [33]. The gene discussed is CD8A; the disease is rheumatoid arthritis.